MISSISSAUGA, ON, Aug. 1, 2024
/CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF)
("Cipher" or the "Company") today announced that it
will release its financial results for the second quarter of 2024
after the market close on Thursday, August
8, 2024. The Company will also hold a conference call on
Friday, August 9, 2024 at
8:30AM ET to discuss the results and
corporate developments.
CONFERENCE CALL DETAILS
|
DATE:
|
August 9,
2024
|
|
TIME:
|
8:30AM
|
|
DIAL-IN
NUMBER:
|
(+1) 437-900-0527 or
888-510-2154
|
|
REPLAY:
|
(+1) 289-819-1450 or
888-660-6345 Code: 28622#
|
|
Expires: August 16,
2024
|
|
WEBCAST:
|
https://app.webinar.net/0Lpez7dn8v4
|
About Cipher Pharmaceuticals Inc.
Cipher Pharmaceuticals (TSX: CPH) (OTCQX: CPHRF) is a specialty
pharmaceutical company with a robust and diversified portfolio of
commercial and early to late-stage products, mainly in dermatology.
Cipher acquires products that fulfill unmet medical needs, manages
the required clinical development and regulatory approval process,
and currently markets those products in Canada, the U.S.,
and South America. For more information,
visit www.cipherpharma.com.
SOURCE Cipher Pharmaceuticals Inc.
